Current Pharmaceutical Design

Are Drugs Always the Proper Solution to Therapeutic Dilemmas? Non-drug Approaches to the Post-traumatic Stress “Waking Corpse” Syndrome
pp. 1-4(4)
Authors: Laios, Konstantinos; Tsoucalas, Gregory; Vrachatis, Dimitrios A.; Charalampakis, Antonis; Androutsos, Gregory; Karamanou, Marianna

Novel Targets for Therapeutic Intervention in Inflammatory Bowel Disease: Research Drives Clinic
pp. 5-6(2)
Authors: Argollo, Marjorie; Danese, Silvio

Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that?
pp. 7-12(6)
Authors: Argollo, Marjorie; Fiorino, Gionata; Gilardi, Daniela; Furfaro, Federica; Roda, Giulia; Loy, Laura; Allocca, Mariangela; Peyrin-Biroulet, Laurent; Danese, Silvio

Biosimilars in IBD: Will it Benefit to Patients, Physicians or the Health Care System?
pp. 13-18(6)
Authors: Gonczi, Lorant; Ilias, Akos; Kurti, Zsuzsanna; Lakatos, Peter L.

Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?
pp. 19-24(6)
Authors: D'Amico, Ferdinando; Roda, Giulia; Peyrin-Biroulet, Laurent; Danese, Silvio

Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease?
pp. 25-31(7)
Authors: Argollo, Marjorie C.; Allocca, Mariangela; Furfaro, Federica; Peyrin-Biroulet, Laurent; Danese, Silvio

JAK Inhibition: The Most Promising Agents in the IBD Pipeline?
pp. 32-40(9)
Authors: Fernández-Clotet, Agnès; Castro-Poceiro, Jesús; Panés, Julián

Cell-based Therapy for Perianal Fistulising Crohn’s Disease
pp. 41-46(6)
Authors: Kotze, Paulo G.; Spinelli, Antonino; Lightner, Amy Lee

Anti-fibrotic Drugs for Crohn’s Disease: Ready for Prime Time?
pp. 47-56(10)
Authors: Argollo, Marjorie; Gilardi, Daniela; Roda, Giulia; Fiorino, Gionata; Peyrin-Biroulet, Laurent; Danese, Silvio

Novel Targets For Therapeutic Intervention in Inflammatory Bowel Disease. What is the Best Way to Assess the Safety Profile of a Drug?
pp. 57-63(7)
Authors: Yzet, Clara; Tse, Stacy S.; Kayal, Maia; Hirten, Robert; Colombel, Jean-Frédéric

Are We Ready to Include Prognostic Factors in Inflammatory Bowel Disease Trials?
pp. 64-68(5)
Authors: Lindholm, Christopher R.; Siegel, Corey A.

Particularities of IBD Trials in Children
pp. 69-72(4)
Author: Turner, Dan

Testosterone Replacement Therapy Has Limited Effect on Increasing Bone Mass Density in Older Men: a Meta-analysis
pp. 73-84(12)
Authors: Junjie, Wang; Dongsheng, Hao; Lei, Sun; Hongzhuo, Li; Changying, Sun

Current Drugs and Nutraceuticals for the Treatment of Patients with Dyslipidemias
pp. 85-95(11)
Authors: Scognamiglio, Michele; Costa, Dario; Sorriento, Antonio; Napoli, Claudio

A Uniquely Modified DKL-based Peptide Probe for Positron Emission Tomography Imaging
pp. 96-103(8)
Authors: Liu, Yi; Wang, Zhengjie; Li, Xiang; Kang, Fei; Ma, Xiaowei; Yang, Weidong; Ma, Wenhui; Wang, Jing